Trexquant Investment LP Biomea Fusion, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$13.44 - $23.02 $424,341 - $726,810
31,573 New
31,573 $434,000
Q3 2022

Nov 14, 2022
BUY
$9.51 - $13.61 $125,284 - $179,298
13,174 New
13,174 $129,000
Q2 2022

Aug 11, 2022
SELL
$3.0 - $12.03 $92,025 - $369,020
-30,675 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$4.39 - $9.03 $134,663 - $276,995
30,675 New
30,675 $137,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $114M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email